共 27 条
- [21] Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naive trachoma-endemic Tanzanian community[J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (07):Ramadhani, Athumani M.Derrick, TamsynMacleod, DavidMassae, PatrickMalisa, AiwedaMbuya, KelvinMtuy, TaraMakupa, WilliamRoberts, Chrissy H.Bailey, Robin L.Mabey, David C. W.Holland, Martin J.Burton, Matthew J.
- [22] Six months effective ocular drug levels and protection against laser CNV in a cynomolgus monkey after a single ocular administration of a biodegradable microsphere delivery system releasing a highly potent anti-VEGF domain antibody based molecule.[J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)Catchpole, Ian R.Adamson, PeterWilde, ThomasDobrzynski, EricSychertz, CarolinePolsky, RoddHaworth, RichardTang, Chi-ManSmal, JosVan der Zwan, Judith
- [23] Experimental Forum 2: Two Years After the 2020 Food and Drug Administration Guidance on E-Cigarette Flavors (vol 112, pg 995, 2022)[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2022, 112 (10) : E5 - E5Dasgupta, N.Morabia, A.
- [24] Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-level of loxacin and 14C-chloroquine in pigmented rats[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) : 977 - 983Tanaka, MTakashina, HTsutsumi, S
- [25] Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin[J]. PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (03):Komlan, KossiVossberg, Patrick S.Gantin, Richard G.Solim, TchalimKorbmacher, FrancoisBanla, MebaPadjoudoum, KoffiKarabou, PotchoziouKoehler, CarstenSoboslay, Peter T.
- [26] Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern Uganda[J]. BMC INFECTIOUS DISEASES, 2023, 23 (01) : 72Echodu, Dorothy C.Yeka, AdokeEganyu, ThomasOdude, WycliffBukenya, FredAmoah, BenjaminWanzira, HumphreyColborn, KathrynElliott, Richard C.Powell, Suzanne E.Kilama, MaxwellMulebeke, RonaldNankabirwa, JoaniterGiorgi, EmanueleRoskosky, MellisaOmoding, OsbornGonahasa, SamuelOpigo, Jimmy
- [27] Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern Uganda[J]. BMC Infectious Diseases, 23Dorothy C. EchoduAdoke YekaThomas EganyuWycliff OdudeFred BukenyaBenjamin AmoahHumphrey WanziraKathryn ColbornRichard C. ElliottSuzanne E. PowellMaxwell KilamaRonald MulebekeJoaniter NankabirwaEmanuele GiorgiMellisa RoskoskyOsborn OmodingSamuel GonahasaJimmy Opigo